Immunoblology of asthma and rhinitis: Pathogenic factors and therapeutic options

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1778-1787

  Casale, T B ^a   Lazarus, S C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; COMORBIDITY; CONFERENCE PAPER; HUMAN; IMMUNOBIOLOGY; IMMUNOPATHOGENESIS; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; RHINITIS;

EID: 0032746472     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.ats7-99     Document Type: Conference Paper

References (95)

1. Church, M. K., and F. Levi-Schaffer. 1997. Updates on cells and cytokines: the human mast cell. J. Allergy Clin. Immunol. 99:155-160.
2. Borish, L., and L. J. Rosenwasser. 1996. Update on cytokines. J. Allergy Clin. Immunol. 97:719-734.
3. Barnes, P. J. 1994. Cytokines as mediators of chronic asthma. Am. J. Respir. Crit. Care Med. 150(Suppl.):S42-S49.
4. Center, D. M., H. Kornfeld, and W. W. Cruikshank. 1997. Interleukin-16. Int. J. Biochem. Cell Biol. 29:1231-1234.
5. + and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:3539-3544.
6. Shaver, J. R., J. J. O'Connor, M. Pollice, S. K. Cho, G. C. Kane, J. E. Fish, and S. P. Peters. 1995. Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects Am. J. Respir. Crit. Care Med. 152:1189-1197.
7. Laberge, S., and D. M. Center. 1996. The role of T cells in asthma. In A. R. Leff, editor. Pulmonary and Critical Care Pharmacology and Therapeutics. McGraw-Hill, New York.
8. Laberge, S., W. W. Cruikshank, H. Kornfeld, and D. M. Center. 1995. Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ cells is independent of transcription and translation: evidence for constitutive protein synthesis and storage. J. Immunol. 55: 2902-2910.
9. Cruikshank, W. W., A. Long, R. Tarpy, H. Kornfeld, M. P. Carroll, L. Teran, S. Holgate, and D. M. Center. 1995. Early identification of IL-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1αa (MIP1α) in bronchoalveolar lavage fluid of antigen challenged asthmatics. Am. J. Respir. Cell Mol. Biol. 13:738-747.
10. Lim, K. G., H.-C. Wan, P. T. Bozza, M. B. Resnick, D. T. Wong, W. W. Cruikshank, H. Kornfeld, D. M. Center, and P. F. Weller. 1996. Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor) and RANTES. J. Immunol. 156: 2566-2570.
11. Center, D. M., H. Kornfeld, and W. W. Cruikshank. 1996. Interleukin-16 and its functions as a CD4 ligand. Immunol. Today 17:476-481.
12. Baroody, F. M., and R. M. Naclerio. 1996. Allergic rhinitis. In R. R. Rich, editor. Clinical Immunology: Principles and Practice. C. V. Mosby, St. Louis, MO. 889-908.
13. Iliopoulos, O., D. Proud, J. F. Adkinson, Jr., P. S. Norman, A. Kagey-Sobotka, L. M. Lichtenstein, and R. M. Naclerio. 1990. Relationship between the early, late and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J. Allergy Clin. Immunol. 86:851-861.
14. Hamann, K. J. 1996. Inflammatory cells in airways. In A. R. Leff, editor. Pulmonary and Critical Care Pharmacology and Therapeutics. McGraw-Hill, New York. 355-369.
15. Kroegel, C., J.-C. Virchow, Jr., W. Luttmann, C. Walker, and J. A. Warner. 1994. Pulmonary immune cells in health and diseae: the eosinophil leukocyte. Eur. Respir. J. 7:519-543.
16. Shaver, J. R., J. G. Zangrilli, S.-K. Cho, R. A. Cirelli, M. Pollice, A. T. Hastie, J. E. Fish, and S. P. Peters. 1997. Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. Am. J. Respir. Crit. Care Med. 155:442-448.
17. John, M., S. J. Hirst, P. J. Jose, A. Robichaud, N. Berkman, C. Witt, C. H. C. Twort, P. J. Barnes, and K. F. Chung. 1997. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J. Immunol. 158:1841-1847.
18. Einarsson, O., G. P. Geba, Z. Zhou, M. L. Landry, R. A. Panettieri, Jr., D. Tristam, R. Welliver, A. Metinko, and J. A. Elias. 1995, Interleukin-11 in respiratory inflammation. Ann. N. Y. Acad. Sci. 762:31-40.
19. Baraniuk, J. N. 1995. The role of sensory neuropeptides in airway hyperresponsiveness. Pulm. Pharmacol. 8:195-207.
20. Barnes, P. J., J. N. Baraniuk, and M. G. Belvisi. 1991. Neuropeptides in the respiratory tract. Part I and Part II. Am. Rev. Respir. Dis. 144: 1187-1198, 1391-1399.
21. Lilly, C. M., L. Kobizik, A. E. Hall, and J. M. Drazen. 1994. Effect of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J. Clin. Invest. 93:2667-2674.
22. McKay, D. M., and J. Bienenstock. 1994. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol. Today 15:533-538.
23. Bozic, C. R., B. Lu, U. E. Hopken, C. Gerard, and N. P. Gerard. 1996. Neurogenic amplification of immune complex inflammation. Science 273:1722-1725.
24. Dray, A., L., Urban, and A. Dickenson. 1994. Pharmacology of chronic pain. Trends Pharmacol. Sci. 15:190-197.
25. Matsuda, H., M. D. Coughlin, H. Bienenstock, and J. A. Denburg. 1988. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc. Natl. Acad. Sci. U.S.A. 85:6508-6512.
26. Piedimonte, G., D. M. McDonald, and J. A. Nadel. 1991. Neutral endopeptidase and kininase II mediate glucncorticoid inhibition of neurogenic inflammation in the rat trachea. J Clin. Invest. 88:40-44.
27. Piedimonte, G., J. A. Nadel, E. Umeno, and D. M. McDonald. 1990. Sendai virus infection potentiates neurogenic inflammation in the rat trachea. J. Appl. Physiol. 68:754-760.
28. Koto, H., H. Aizawa, S. Takata, H. Inoue, and N. Hara. 1995. An important role of tachykinins in ozone-induced airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 151:1763-1769.
29. Bowden, J. J., T. R. Schoeb, J. R. Lindsey, and D. M. McDonald. 1994. Dexamethasone and oxytetracycline reverse the potentiation of neurogenic inflammation in airways of rats with Mycoplasma pulmonis infection. Am. J. Respir. Crit. Care Med. 150:1391-1401.
30. Fryer, A. D., and M. Wills-Karp. 1991. Dysfunction of Mγmuscarinic receptors in pulmonary parasympathetic nerves after antigen challenge. J. Appl. Physiol. 71:2255-2261.
31. 2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea pig. Br. J. Pharmacol. 102:267-271.
32. 2 muscarinic receptor function. J. Appl. Physiol. 76:1088-1097.
33. 2 receptor function in antigen challenged guinea pigs. Am. J. Phsyiol. Lung Cell Mol. Physiol. 273:L93-L103.
34. 2 muscarinic receptor function in antigen challenged guinea-pigs. Am. J. Respir. Cell Mol. Biol. 12:320-328.
35. 2 muscarinic receptors in antigen-challenged guinea-pig airways. J. Clin. Invest. 99:2036-2044.
36. 2 receptor. J. Clin. Invest. 91:1314-1318.
37. 2 receptor function of antigen challenged guinea-pigs in vivo. J. Clin. Invest. 100:2254-2262.
38. Casale, T. B., and J. N. Baraniuk. 1998. Neurogenic Control of Inflammation and Airway Function. In E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., J. W. Yunginger, and W. W. Busse, editors. Allergy: Principles and Practice, 5th Edition. Mosby-Year Book, St. Louis, MO. 183-203.
39. Smart, S. J., and T. B. Casale. 1997. Abnormal autonomic control in respiratory disease. In P. J. Barnes, editor. Autonomie Control of the Respiratory System. Harwood Academic Publishers, Chur, Switzerland, 313-338.
40. Weiss, K. B., P. J. Gergen, and D. K. Wagener. 1993. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. Am. Rev. Public Health 14:491-513.
41. Weiss, K. B., P. J. Gergen, and T. A. Hodgson. 1992. An economic evaluation of asthma in the United States. N. Engl. J. Med. 326:862-866.
42. Expert Panel Report II. 1997. Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. NIH Publication No. 97-4051.
43. Shirakawa, T., T. Enomoto, S. Shimazu, and J. M. Hopkin. 1997. The inverse association between tuberculin responses and atopic disorder. Science 275:77-79.
44. Goh, D. Y., F. T. Chew, S. C. Quek, and B. W. Lee. 1996. Prevalence and severity of asthma, rhinitis, and eczema in Singapore schoolchildren. Arch. Dis. Child 74:131-135.
45. International Rhinitis Management Working Group. 1994. International consensus report on diagnosis and management of rhinitis. Allergy 49: 1-34.
46. Norman, E., L. Rosenhall, L. Nystrom, E. Jonnson, and N. Stjernberg. 1994. Prevalence of positive skin prick tests, allergic asthma, and rhinoconjunctivitis in teenagers in northern Sweden. Allergy 49:808-815.
47. Droste, J. H., M. Kerhof, J. G. de Monchy, J. P. Schouten, and B. Rijcken. 1996. Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. J. Allergy Clin. Immunol. 67:922-932.
48. Meltzer, E. O., R. J. Tyrell, D. Rich, and C. C. Wood. 1995. A pharmacologic continuum in the treatment of rhinorrhea: the clinician as economist. J. Allergy Clin. Immunol 95:1147-1152.
49. Nightingale, C. H. 1996. Treating allergic rhinitis with second-generation antihistamines. Pharmacotherapy 16:905-914.
50. Juniper, E. F., and G. H. Guyatt. 1991. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy 22:77-83.
51. Juniper, E. G., G. H. Guyatt, and J. Dolovich. 1994. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J. Allergy Clin. Immunol. 93:413-423.
52. Wright, A. L., C. J. Holberg, F. D. Martinez, M. Halonen, W. J. Morgan, and L. M. Taussig. 1994. Epidemiology of physician diagnosed allergic rhinitis in childhood. Pediatrics 94:895-901.
53. Yunginger, J. W., C. F., Reed, E. J. O'Connell, L. J. Melton III, W. M. O'Fallon, and M. D. Silverstein. 1992. A community-based study of the epidemiology of asthma. Am. Rev. Respir. Dis. 146:888-894.
54. Kraft, M., J. A. Torvik, J. B. Trudeau, S. F. Wendel, and R. J. Martin. 1996. Theophylline: potential antiinflammatory effects in nocturnal asthma. J. Asthma Clin. Immunol. 97:1242-1246.
55. Robinson, D., O. Hamid, S. Ying, A. Bentley, B. Assoufi, S. Durham, and A. B. Kay. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am. Rev. Respir. Dis. 148:40-406.
56. Suissa, S., R. Dennis, P. Ernst, O. Sheehy, and S. Wood-Dauphinec. 1997. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 126:177-183.
57. Wenzel, S. E., J. B. Trudeau, D. A. Kaminsky, J. Cohn, R. M. Martin, and J. Y. Westcott. 1995. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 152:897-905.
58. Newman, S. P., F. Moren, and S. W. Clarke. 1987. Deposition pattern of nasal sprays in man. Rhinology 34:198-200.
59. Mygind, N., and V. Lund. 1996. Topical corticosteroid therapy of rhinitis. Clin. Immunother. 5:122-136.
60. Howarth, P. H. 1997. Corticosteroids in the treatment of allergic rhinitis. In R. P. Schleimer, W. W. Busse, and P. M. O'Byrne, editors. Inhaled Glucocorticoids in Asthma. Marcel Dekker, New York, 521-550.
61. Henriksen, J. M., and A. Wenzel, 1984. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am. Rev. Respir. Dis. 130:1014-1018.
62. Aubier, M., J. Levy, C. Clerici, F. Neukirch, and D. Herman. 1992. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am. Rev. Respir. Dis. 146:122-126.
63. Borum, P., H. Gronborg, and N. Mygind. 1987. Seasonal allergic rhinitis and depot-injection of corticosteroid: evaluation of the efficacy of medication early and late in the season based on detailed symptoms recording. Allergy 42:26-32.
64. Wihl, J. A., B. N. Petersen, L. N. Petersen, G. Gundersen, K. Bresson, and N. Mygind. 1985. Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis. J. Allergy Clin. Immunol. 75:720-727.
65. Bousquet, J., L. B. Lebel, I. Chanal, A. Morel, and F. B. Michel. 1988. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. J. Allergy Clin. Immunol. 82:881-887.
66. Naclerio, R. M., A. Kagey-Sobotka, L. M. Lichtenstein, L. Freidhoff, and D. Proud. 1990. Terfenadine, an H1-antihistamine, inhibits histamine release in vivo in the human. Am. Rev. Respir. Dis. 142:167-171.
67. Ciprandi, G., C. Pronzato, V. Ricca, P. Varese, G. S. del Giacco, and G. W. Canonica. 1995. Terfenadine exerts antiallergic activity reducing TCAM-I expression on nasal epithelial cells in patients with pollen allergy. Clin. Exp. Allergy 25:871-878.
68. Borum, P., and N. Mygind, 1990. Anticholinergic treatment of watery rhinorrhea. Am. J Rhinol. 4:1-5.
69. Rafferty, P., R. Beasley, and S. T. Holgate. 1987. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′-monophosphate in atopic asthma. Am. Rev. Respir. Dis. 136:369-373.
70. White, M. V., J. E. Slater, and M. A. Kaliner. 1987. Histamine and asthma. Am. Rev Respir. Dis. 135:1165-1176.
71. Herxheimer, H. 1949. Antihistamines in bronchial asthma. Br. Med. J. 2:901-905.
72. Taytard, A., D. Beaumont, J. Pujet, M. Saphe, and P. Lewis. 1987. Treatment of bronchial asthma with lerfenadine: a randomized controlled trial. Br. J. Clin. Pharmacol. 24:743-746.
73. Spector, S., N. Lee, R. McNutt, R. M. Katz, W. Huster, S. Siegel, G. Rachelefsky, and A. Tohr. 1992. Effect of terfenadine in asthmatic patients. Ann. Allergy 69:212-216.
74. Noon, L. 1911. Prophylactic inoculation against hay fever. Lancet 1:1572-1573.
75. Nelson, H. S. 1997. Does allergen immunotherapy have a role in the treatment of bronchial asthma? Allergy Asthma Proc. 18:157-162.
76. Barnes, P. J. 1996. Is there a role for immunotherapy in the treatment of asthma? No [Editorial]. Am. J. Respir. Crit. Care Med. 154:1227-1228.
77. Norman, P. S. 1996. Is there a role for immunotherapy in the treatment of asthma? Yes [Editorial]. Am. J. Respir. Crit. Care Med. 154:1225-1226.
78. Bousquet, J., R. Lockey, and H. Malling. 1998, WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Eur. J. Allergy Clin. Immunol. 53(Suppl. 44):1-42.
79. Giovane, A. L., M. Bardare, G. Passalacqua, S. Ruffioni, A. Scordamaglia, E. Ghezzi, and G. W. Canonica, 1994. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in pediatric patients. Clin. Exp. Allergy 24:53-59.
80. Nelson, H. S., J. Oppenheimer, G. A. Vatsia, and A. Buchmeier. 1993. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J. Allergy Clin. Immunol. 92: 229-236.
81. Passalacqua, G., M. Albano, S. Ruffino, C. Pronzato, A. M. Riccio, L. DeBerardino, A. Scordamaglia, and G. W. Canonica. 1995. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. Am. J. Respir. Crit. Care Med. 152:461-466.
82. Piazza, I., and N. Bizzara, 1993. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus. Ann. Allergy 71:461-469.
83. Creticos, P. S., C. F., Reed, P. S. Norman, J. Khoury, N. Adkinson, C. R. Buncher, W. W. Busse, R. K. Bush, J. Gadde, J. T. Li, H. B. Richerson, R. R. Rosenthal, W. R. Solomon, P. Steinberg, and U. W. Yunginger. 1996. Ragweed immunotherapy in adult asthma. N. Engl. J. Med. 334:501-506.
84. Abramson, M. J., R. M. Puy, and J. M. Weiner. 1995. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am. J. Respir. Crit. Care Med, 151:969-974.
85. Adkinson, N. F., Jr., P. A. Eggleston, D. Eney, E. O. Goldstein, K. C. Schuberth, J. R. Bacon, R. G. Hamilton, M. E. Weiss, H. Arshad, C. L. Meinert, J. Tonascia, and B. Wheeler. 1997. A controlled trial of immunotherapy for asthma in allergic children. N. Engl. J. Med. 336: 324-331.
86. Nieklas, R., I. L. Bernstein, J. Blessing-Moore, S. Fineman, A. Gutman, R. Lee, J. Li, W. Berger, and S. Spector. 1996. Practice parameters for allergen immunotherapy. J. Allergy Clin. Immunol. 98:1-11.
87. Townley, R. G., M. Glass, and M. C. Minkwitz. 1995. Six-week, dose-escalation study with Accolate (zafirlukast) in patients with mild to moderate asthma (abstract). Am. J. Respir. Crit. Care Med. 151:A379.
88. Tamaoki, J., M. Kondo, N. Sakai, J. Nakata, H. Takemura, A. Nagai, T. Takizawa, and K. Konno. 1997. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am. J. Respir. Crit. Care Med. 155:1235-1240.
89. Donnelly, A., M. Glass, B. Muller, S. Smart, J. Hutson, M. Minkwitz, and T. B. Casale, 1993. Leukotriene D4 (LTD4) antagonist ICI 204,219 relieves allergic ragweed allergic rhinitis symptoms. J. Allergy Clin. Immunol. 91:977-1004.
90. Knapp, H. R. 1990. Reduced allergen-induced nasal symptoms and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N. Engl. J. Med. 323:1745-1748.
91. Naclerio, R. M., D. Bartenfelder, D. Proud, A. G. Togias, D. A. Meyers, A. Kagey-Sabotka, P. S. Norman, and L. M. Lichtenstein. 1985. Theophylline reduced the response to nasal challenge with antigen. Am. J. Med. 79:43-47.
92. 1992. International Consensus Report on Diagnosis and Management of Asthma. Allergy 47:161.
93. 1994. International Consensus Report on the Diagnosis and Management of Asthma. Allergy 49:1-33.
94. Bousquet, J., P. Godard, and F. B. Michel. 1992. Antihistamines in the treatment of asthma. Eur. Respir. J. 5:1137-1142.
95. 1995. Global Strategy for Asthma Management and Prevention. WHO/ NHLBI Workshop Report. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. Report No. 95-3659.